SCHEMBL395535

SCHEMBL395535

CC(C)(C)N(CC(=O)OCC[Si](C)(C)C)C(=O)OCOC(=O)c1ccc(C(=O)c2ccccc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 1/20 0.37
LMNA P02545 4/20 0.36
MAPT P10636 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
TDP1 Q9NUW8 3/20 0.35
MAPK1 P28482 1/20 0.34
HIF1A Q16665 1/20 0.34
GAA P10253 1/20 0.34
PPARG P37231 2/20 0.34
ELANE P08246 2/20 0.33
ALDH1A1 P00352 1/20 0.33
TSHR P16473 1/20 0.33
HSD17B10 Q99714 1/20 0.33
ALOX5 P09917 1/20 0.33
HTR1A P08908 1/20 0.33
CYP2D6 P10635 1/20 0.33
SCN1A P35498 1/20 0.33
SLC6A3 Q01959 1/20 0.33
SCN5A Q14524 1/20 0.33
SCN2A Q99250 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL395726 0.84 KMT2A (0.48) PPARALMNAMAPTL3MBTL1TDP1
SCHEMBL390381 0.83 MAPK1 (0.41) PPARALMNAMAPTTDP1MAPK1
SCHEMBL390379 0.80 KDM4E (0.40) LMNAMAPTL3MBTL1TDP1MAPK1
SCHEMBL393672 0.79 AKR1B10 (0.42) PPARALMNAL3MBTL1ALDH1A1
SCHEMBL392819 0.75 MAPT (0.49) LMNAMAPTL3MBTL1TDP1MAPK1
SCHEMBL393109 0.74 KMT2A (0.44) LMNAMAPTL3MBTL1TDP1MAPK1
SCHEMBL393493 0.74 MAPT (0.45) LMNAMAPTL3MBTL1TDP1MAPK1
SCHEMBL395276 0.74 MAPT (0.45) LMNAMAPTL3MBTL1TDP1MAPK1
SCHEMBL392988 0.74 KDM4E (0.46) MAPTL3MBTL1MAPK1HIF1AELANE
SCHEMBL395232 0.74 MAPT (0.44) LMNAMAPTTDP1GAAELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101590-B2 9-aminocarbonylsubstituted derivatives of glycylcyclines WYETH LLC (US) 2012-01-24 US disclosed
EP-1919879-A1 9-AMINOCARBONYLSUBSTITUTED DERIVATIVES OF GLYCYLCYCLINES Wyeth a Corporation of the State of Delaware (US) 2008-05-14 EP disclosed
WO-2007027599-A1 9-AMINOCARBONYLSUBSTITUTED DERIVATIVES OF GLYCYLCYCLINES WYETH (US) 2007-03-08 WO disclosed
US-20070049564-A1 9-Aminocarbonylsubstituted derivatives of glycylcyclines WYETH (US) 2007-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070049564-A1 9-Aminocarbonylsubstituted derivatives of glycylcyclines Q6ZSR9, GMPS, RPS10 PPARA 4298/4885LMNA 2954/4885MAPT 4452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.